The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis.
Arthur
A
Kavanaugh
Stanley
S
Cohen
John J
JJ
Cush
D018501:Antirheumatic Agents / Q000191:economics / Q000276:immunology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha